HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.

Abstract
We previously demonstrated that Siglec-15, a member of the Siglec family of glycan-recognition proteins, is expressed on a subset of macrophages and preferentially recognizes the sialyl-Tn (sTn) antigen, a tumor-associated glycan structure. In this study, we report on the biological significance of the Siglec-15-mediated interaction between monocytes/macrophages and cancer cells. Siglec-15 is expressed on tumor-associated macrophages (TAMs) in various human tumor tissues. We further demonstrated that its expression is substantially elevated in macrophage colony-stimulating factor-induced M2-like macrophages, which produced more transforming growth factor-β (TGF-β) in response to sTn-positive cells than to negative cells. We designed a co-culture model of THP-1 (human monocytic leukemia) cells and H157 (human lung carcinoma) cells mimicking the interaction between monocytes/macrophages and cancer cells that recapitulated the enhanced TGF-β production in Siglec-15 expressing THP-1 cells by the cellular interaction with sTn expressing H157 cells. The enhanced TGF-β production required a direct interaction between the two cell lines through sialic acids. Siglec-15 associates with adaptor protein DNAX activation protein of 12 kDa (DAP12) at the binding determinant Lys(274) in the transmembrane domain and transduces a signal to spleen tyrosine kinase (Syk). The enhanced TGF-β secretion was significantly attenuated by Syk inhibitor treatment of THP-1 cells or by substitution of the Siglec-15 Lys(274) to Ala, which disrupts the molecular interaction between Siglec15 and DAP12. These findings indicate that Siglec-15 recognizes the tumoral sTn antigen and transduces a signal for enhanced TGF-β secretion in TAMs and further suggest that Siglec-15 on macrophages may contribute to tumor progression by the TGF-β-mediated modulation of intratumoral microenvironments.
AuthorsRina Takamiya, Kazuaki Ohtsubo, Shinji Takamatsu, Naoyuki Taniguchi, Takashi Angata
JournalGlycobiology (Glycobiology) Vol. 23 Issue 2 Pg. 178-87 (Feb 2013) ISSN: 1460-2423 [Electronic] England
PMID23035012 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Antigens, Tumor-Associated, Carbohydrate
  • Immunoglobulins
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • SIGLEC15 protein, human
  • TYROBP protein, human
  • Transforming Growth Factor beta
  • sialosyl-Tn antigen
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
Topics
  • Adaptor Proteins, Signal Transducing (immunology, metabolism)
  • Antigens, Tumor-Associated, Carbohydrate (immunology, metabolism)
  • Cell Line, Tumor
  • Coculture Techniques
  • Humans
  • Immunoglobulins (immunology, metabolism)
  • Intracellular Signaling Peptides and Proteins (immunology, metabolism)
  • Macrophages (immunology, metabolism)
  • Membrane Proteins (immunology, metabolism)
  • Monocytes (immunology, metabolism)
  • Protein Binding
  • Protein-Tyrosine Kinases (immunology, metabolism)
  • Signal Transduction
  • Syk Kinase
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: